These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9137907)

  • 61. Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen.
    Izenwasser S; Newman AH; Katz JL
    Eur J Pharmacol; 1993 Oct; 243(2):201-5. PubMed ID: 8276070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors.
    Izenwasser S; Terry P; Heller B; Witkin JM; Katz JL
    Eur J Pharmacol; 1994 Oct; 263(3):277-83. PubMed ID: 7843265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
    Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
    Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Loss of autoreceptor functions in mice lacking the dopamine transporter.
    Jones SR; Gainetdinov RR; Hu XT; Cooper DC; Wightman RM; White FJ; Caron MG
    Nat Neurosci; 1999 Jul; 2(7):649-55. PubMed ID: 10404198
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Voltage-dependency of the dopamine transporter in rat brain.
    Zahniser NR; Gerhardt GA; Hoffman AF; Lupica CR
    Adv Pharmacol; 1998; 42():195-8. PubMed ID: 9327877
    [No Abstract]   [Full Text] [Related]  

  • 67. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
    Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T
    J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.
    Gulley JM; Zahniser NR
    Eur J Pharmacol; 2003 Oct; 479(1-3):139-52. PubMed ID: 14612145
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dynamic regulation of the dopamine transporter.
    Mortensen OV; Amara SG
    Eur J Pharmacol; 2003 Oct; 479(1-3):159-70. PubMed ID: 14612147
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design and synthesis of a biotinylated dopamine transporter ligand for the purification and labeling of dopaminergic neurons.
    Zimmermann K; Hengerer B
    Bioorg Med Chem Lett; 1998 Feb; 8(3):261-6. PubMed ID: 9871666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopamine action and metabolism in the kidney.
    Aperia A
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):39-45. PubMed ID: 7850410
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of dopamine transporter mRNA levels in the central nervous system.
    Hoffman BJ; Palkovits M; Paćak K; Hansson SR; Mezey E
    Adv Pharmacol; 1998; 42():202-6. PubMed ID: 9327879
    [No Abstract]   [Full Text] [Related]  

  • 73. Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter.
    Simantov R; Blinder E; Ratovitski T; Tauber M; Gabbay M; Porat S
    Neuroscience; 1996 Sep; 74(1):39-50. PubMed ID: 8843076
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dopamine transporter, alcoholism and other diseases.
    Goldman D
    Nat Med; 1995 Jul; 1(7):624-5. PubMed ID: 7585136
    [No Abstract]   [Full Text] [Related]  

  • 75. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system.
    Takahashi T; Deng Y; Maruyama W; Dostert P; Kawai M; Naoi M
    J Neural Transm Gen Sect; 1994; 98(2):107-18. PubMed ID: 7734108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter.
    Chen N; Appell M; Berfield JL; Reith ME
    Eur J Pharmacol; 2003 Oct; 478(2-3):89-95. PubMed ID: 14575792
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Functional regulation of serotonin transporter, a molecule involved in the pathogenesis of anxiety disorder].
    Sakai N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):101-10. PubMed ID: 15291238
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Localization of dopamine transporter protein by microscopic histochemistry.
    Kuhar MJ; Vaughan R; Uhl G; Cerruti C; Revay R; Freed C; Nirenburg M; Pickel V
    Adv Pharmacol; 1998; 42():168-70. PubMed ID: 9327870
    [No Abstract]   [Full Text] [Related]  

  • 79. Dopamine transporter and nitric oxide synthase in hypoxic-ischemic brain.
    Meng SZ; Ohyu J; Itoh M; Takashima S
    Pediatr Neurol; 2000 Feb; 22(2):115-21. PubMed ID: 10738916
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recent biochemical studies of the dopamine transporter--a CNS drug target.
    Kuhar MJ
    Life Sci; 1998; 62(17-18):1573-5. PubMed ID: 9585138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.